SE9003903D0 - New pharmaceutical formulations - Google Patents

New pharmaceutical formulations

Info

Publication number
SE9003903D0
SE9003903D0 SE9003903A SE9003903A SE9003903D0 SE 9003903 D0 SE9003903 D0 SE 9003903D0 SE 9003903 A SE9003903 A SE 9003903A SE 9003903 A SE9003903 A SE 9003903A SE 9003903 D0 SE9003903 D0 SE 9003903D0
Authority
SE
Sweden
Prior art keywords
pharmaceutical formulations
new pharmaceutical
substance
hydrophilid
ion
Prior art date
Application number
SE9003903A
Other languages
English (en)
Inventor
B M Lindstedt
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9003903A priority Critical patent/SE9003903D0/sv
Publication of SE9003903D0 publication Critical patent/SE9003903D0/sv
Priority to YU186791A priority patent/YU186791A/sh
Priority to SI9111867A priority patent/SI9111867B/sl
Priority to IE413691A priority patent/IE914136A1/en
Priority to DE69133623T priority patent/DE69133623D1/de
Priority to PCT/SE1991/000814 priority patent/WO1992010171A1/en
Priority to JP50011692A priority patent/JP3276956B2/ja
Priority to AT91920634T priority patent/ATE444737T1/de
Priority to HU9301671A priority patent/HU218661B/hu
Priority to AU89305/91A priority patent/AU656346B2/en
Priority to EP91920634A priority patent/EP0560816B1/en
Priority to CA002097176A priority patent/CA2097176C/en
Priority to US07/802,325 priority patent/US5707656A/en
Priority to PT99720A priority patent/PT99720B/pt
Priority to IS3787A priority patent/IS1749B/is
Priority to FI932553A priority patent/FI932553A0/fi
Priority to NO932053A priority patent/NO305536B1/no
Priority to US08/216,028 priority patent/US5709882A/en
Priority to EE9400416A priority patent/EE03105B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
SE9003903A 1990-12-07 1990-12-07 New pharmaceutical formulations SE9003903D0 (sv)

Priority Applications (19)

Application Number Priority Date Filing Date Title
SE9003903A SE9003903D0 (sv) 1990-12-07 1990-12-07 New pharmaceutical formulations
YU186791A YU186791A (sh) 1990-12-07 1991-11-27 Nove farmaceutske formulacije koje sadrže farmaceutski aktivnu jonizujuću supstancu, kao i postupak za njihovo dobijanje
SI9111867A SI9111867B (en) 1990-12-07 1991-11-27 New pharmaceutical formulations containing active ionizable substance as well as procedure for their preparation
IE413691A IE914136A1 (en) 1990-12-07 1991-11-28 New pharmaceutical formulations containing a¹pharmacologically active ionizable substance as well as a¹process for the preparation thereof
PCT/SE1991/000814 WO1992010171A1 (en) 1990-12-07 1991-12-03 New pharmaceutical formulations containing a pharmacologically active ionizable substance as well as process for the preparation thereof
HU9301671A HU218661B (hu) 1990-12-07 1991-12-03 Eljárás gyógyászatilag hatásos ionos hatóanyag és ioncserélő műgyanta komplexét tartalmazó gyógyszerformák előállítására
CA002097176A CA2097176C (en) 1990-12-07 1991-12-03 New pharmaceutical formulations containing a pharmacologically active ionizable substance as well as process for the preparation thereof
JP50011692A JP3276956B2 (ja) 1990-12-07 1991-12-03 薬理学的に活性なイオン化可能物質を含有する新規な医薬製剤およびその製造法
AT91920634T ATE444737T1 (de) 1990-12-07 1991-12-03 Pharmakologisch aktive ionisierbare substanzen enthaltende neue pharmazeutische formulierungen sowie verfahren zu deren herstellung
DE69133623T DE69133623D1 (de) 1990-12-07 1991-12-03 Haltende neue pharmazeutische formulierungen sowie verfahren zu deren herstellung
AU89305/91A AU656346B2 (en) 1990-12-07 1991-12-03 New pharmaceutical formulations containing a pharmacologically active ionizable substance as well as process for the preparation thereof
EP91920634A EP0560816B1 (en) 1990-12-07 1991-12-03 New pharmaceutical formulations containing a pharmacologically active ionizable substance as well as process for the preparation thereof
US07/802,325 US5707656A (en) 1990-12-07 1991-12-04 Pharmaceutical formulations containing a pharmacologically active ionizable substance as well as process for the preparation thereof
IS3787A IS1749B (is) 1990-12-07 1991-12-06 Aðferð til framleiðslu nýrra lyfjaforma, sem innihalda jónanleg, lyfjafræðilega virk efni
PT99720A PT99720B (pt) 1990-12-07 1991-12-06 Processo para a preparacao de novas composicoes farmaceuticas contendo uma substancia ionizavel com actividade farmacologica
FI932553A FI932553A0 (fi) 1990-12-07 1993-06-04 Nya farmaceutiska formulationer innehaollande ett farmakologiskt aktivtjoniserbart aemne samt process foer framstaellning daerav
NO932053A NO305536B1 (no) 1990-12-07 1993-06-04 FremgangsmÕte for fremstilling av et komprimert oralt preparat
US08/216,028 US5709882A (en) 1990-12-07 1994-03-22 Pharmaceutical formulations containing a pharmacologically active ionizable substance as well as a process for the preparation thereof
EE9400416A EE03105B1 (et) 1990-12-07 1994-11-17 Farmakoloogilist ioniseeruvat toimeainet sisaldavad ravimvormid ja nende valmistamise protsess

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9003903A SE9003903D0 (sv) 1990-12-07 1990-12-07 New pharmaceutical formulations

Publications (1)

Publication Number Publication Date
SE9003903D0 true SE9003903D0 (sv) 1990-12-07

Family

ID=20381122

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9003903A SE9003903D0 (sv) 1990-12-07 1990-12-07 New pharmaceutical formulations

Country Status (17)

Country Link
US (2) US5707656A (sv)
EP (1) EP0560816B1 (sv)
JP (1) JP3276956B2 (sv)
AT (1) ATE444737T1 (sv)
AU (1) AU656346B2 (sv)
CA (1) CA2097176C (sv)
DE (1) DE69133623D1 (sv)
EE (1) EE03105B1 (sv)
FI (1) FI932553A0 (sv)
HU (1) HU218661B (sv)
IE (1) IE914136A1 (sv)
IS (1) IS1749B (sv)
NO (1) NO305536B1 (sv)
PT (1) PT99720B (sv)
SE (1) SE9003903D0 (sv)
WO (1) WO1992010171A1 (sv)
YU (1) YU186791A (sv)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2269679A1 (en) * 1996-12-20 1998-07-02 Warner-Lambert Company Antitussive drugs delivered by partially coated ion exchange resins
US20030118641A1 (en) * 2000-07-27 2003-06-26 Roxane Laboratories, Inc. Abuse-resistant sustained-release opioid formulation
CA2379987A1 (en) * 1999-07-29 2001-02-08 Roxane Laboratories, Inc. Opioid sustained-released formulation
US9820982B2 (en) * 2001-07-06 2017-11-21 Endo Pharmaceuticals Inc. Oxymorphone controlled release formulations
EP1429728A1 (en) * 2001-08-29 2004-06-23 SRL Technologies, Inc. Sustained release preparations
AU2003230805A1 (en) * 2002-04-05 2003-10-27 Penwest Pharmaceuticals Co. Sustained release metoprolol formulations
US7314640B2 (en) * 2003-07-11 2008-01-01 Mongkol Sriwongjanya Formulation and process for drug loaded cores
US20050265955A1 (en) * 2004-05-28 2005-12-01 Mallinckrodt Inc. Sustained release preparations
JP2006296511A (ja) * 2005-04-15 2006-11-02 Transcutaneous Technologies Inc 外用剤、外用剤の塗布方法、イオントフォレーシス装置及び経皮パッチ
JP2006346368A (ja) * 2005-06-20 2006-12-28 Transcutaneous Technologies Inc イオントフォレーシス装置及びその製造方法
WO2007010900A1 (ja) * 2005-07-15 2007-01-25 Transcu Ltd. 貼付位置表示機能付き経皮吸収用パッチ及びイオントフォレーシス装置
JP2007037868A (ja) * 2005-08-05 2007-02-15 Transcutaneous Technologies Inc 経皮投与装置及びその制御方法
US8386030B2 (en) * 2005-08-08 2013-02-26 Tti Ellebeau, Inc. Iontophoresis device
US20070060860A1 (en) * 2005-08-18 2007-03-15 Transcutaneous Technologies Inc. Iontophoresis device
WO2007026671A1 (ja) * 2005-08-29 2007-03-08 Transcu Ltd. センサからの情報により投与すべき薬剤の選定を行うイオントフォレーシス装置
US20090216177A1 (en) * 2005-09-16 2009-08-27 Tti Ellebeau,Inc Catheter-type iontophoresis device
US20070071807A1 (en) * 2005-09-28 2007-03-29 Hidero Akiyama Capsule-type drug-releasing device and capsule-type drug-releasing device system
US20070073212A1 (en) * 2005-09-28 2007-03-29 Takehiko Matsumura Iontophoresis apparatus and method to deliver active agents to biological interfaces
US20090299265A1 (en) * 2005-09-30 2009-12-03 Tti Ellebeau, Inc. Electrode Assembly for Iontophoresis Having Shape-Memory Separator and Iontophoresis Device Using the Same
AU2006299520A1 (en) * 2005-09-30 2007-04-12 Tti Ellebeau, Inc. Iontophoresis device to deliver multiple active agents to biological interfaces
US20090187134A1 (en) * 2005-09-30 2009-07-23 Hidero Akiyama Iontophoresis Device Controlling Amounts of a Sleep-Inducing Agent and a Stimulant to be Administered and Time at Which the Drugs are Administered
US20070197955A1 (en) * 2005-10-12 2007-08-23 Transcutaneous Technologies Inc. Mucous membrane adhesion-type iontophoresis device
US20080193514A1 (en) * 2006-11-02 2008-08-14 Transcu Ltd. Compostions and methods for iontophoresis delivery of active ingredients through hair follicles
JPWO2008087803A1 (ja) * 2007-01-16 2010-05-06 国立大学法人北海道大学 抗酸化成分を封入したイオントフォレーシス用リポソーム製剤
JP2010187707A (ja) * 2007-06-12 2010-09-02 Hokkaido Univ インスリンを封入したイオントフォレーシス用リポソーム製剤
CN102209573A (zh) * 2008-09-10 2011-10-05 透皮株式会社 将基于hpc的粘性液体分配至多孔基材中的设备和方法,例如基于连续匹的工艺
CA2757337A1 (en) * 2009-04-03 2010-10-07 Coating Place, Inc. Modified-release pharmaceutical drug composition

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4983392A (en) * 1983-11-14 1991-01-08 Bio-Mimetics, Inc. Bioadhesive compositions and methods of treatment therewith
US4692462A (en) * 1985-03-18 1987-09-08 Menley & James Laboratories, Ltd. Compositions and method of controlling transdermal penetration of topical and systemic agents
EP0199855A1 (en) * 1985-05-02 1986-11-05 Gist-Brocades N.V. Tablets comprising tromethoprim and a sulfonamide
JPS62223112A (ja) * 1986-03-25 1987-10-01 Rooto Seiyaku Kk 歯周病治療剤
IE62100B1 (en) * 1986-07-30 1994-12-14 Fisons Corp Coated ion exchange resins
DE3740684A1 (de) * 1987-12-01 1989-06-15 Woehr Otto Gmbh Parksystem
MC2025A1 (fr) * 1988-04-20 1990-04-25 Asta Pharma Ag Medicament contenant de l'azelastine et capable de liberer celle-ci de facon controlee
IL90245A (en) * 1988-05-11 1994-04-12 Glaxo Group Ltd Resin adsorption containing ranitidine together with synthetic resin replaces cations, its preparation and pharmaceutical preparations containing it
CA2002492A1 (en) * 1988-11-11 1990-05-11 Sandra T. A. Malkowska Pharmaceutical ion exchange resin composition
US5149523A (en) * 1989-06-20 1992-09-22 Aktiebolaget Hassle Polystyrenesulfonate-drug complex and solid dosage forms thereof

Also Published As

Publication number Publication date
EP0560816A1 (en) 1993-09-22
IS3787A7 (is) 1992-06-08
US5707656A (en) 1998-01-13
ATE444737T1 (de) 2009-10-15
FI932553A (fi) 1993-06-04
PT99720A (pt) 1992-10-30
NO932053D0 (no) 1993-06-04
CA2097176A1 (en) 1992-06-08
AU8930591A (en) 1992-07-08
HU218661B (hu) 2000-10-28
HU9301671D0 (en) 1993-09-28
US5709882A (en) 1998-01-20
NO305536B1 (no) 1999-06-21
HUT64213A (en) 1993-12-28
FI932553A0 (fi) 1993-06-04
JPH06503311A (ja) 1994-04-14
DE69133623D1 (de) 2009-11-19
JP3276956B2 (ja) 2002-04-22
IE914136A1 (en) 1992-06-17
EP0560816B1 (en) 2009-10-07
EE03105B1 (et) 1998-08-17
PT99720B (pt) 2002-04-29
IS1749B (is) 2000-07-11
YU186791A (sh) 1994-04-05
AU656346B2 (en) 1995-02-02
CA2097176C (en) 2002-03-26
NO932053L (no) 1993-07-20
WO1992010171A1 (en) 1992-06-25

Similar Documents

Publication Publication Date Title
SE9003903D0 (sv) New pharmaceutical formulations
NO851170L (no) Lagringsstabile, hurtignedbrytende farmasoeytiske virksomme stoff-presslegemer
ATE95983T1 (de) Graduelle verabreichungsstrukturen fuer kaugummi.
ES2190075T3 (es) Formulaciones farmaceuticas solidas que contienen una mezcla fisica de sulfoalquil-eter-ciclodextrina y un agente terapeutico.
YU174490A (sh) Novi estri tienil-karboksilne kiseline sa aminoalkoholima, njihova kvaterna jedinjenja kao i pripremanje i primena tih jedinjenja
BR9406363A (pt) Composiçao farmacêutica processo para a preparaçao da mesma uso da mesma e processo para o tratamento de doenças relacionadas com o ácido gástrico
ATA84882A (de) Therapeutisches abgabesystem zur verabreichung eines wirkstoffes durch die haut
ES2165640T3 (es) Acidos diaminocarboxilicos sustituidos.
AR032293A1 (es) Estuche farmaceutico
NL192561B (nl) Oogontstekings-werende middelen. Oftalmische preparaten die bepaalde fenylazijnzuurverbindingen bevatten.
NL193907B (nl) Basische ether en farmaceutische samenstelling die de basische ether als actief bestanddeel bevat.
ES2173858T3 (es) Analogos de huperzina a.
DK0957981T3 (da) Rersorvoirer til aflevering af lægemidler ved elektrotransport, indeholdende inerte fyldmaterialer
HU9301672D0 (en) Method for manufacturing solid dosing forms of medicaments with controlled releasing of active agents
SE8901003L (sv) Snabbloesliga preparat
ES2195040T3 (es) Conjugado que incluye un principio activo, un polipeptido y varios polieteres y su uso como medicamento.
ATE254851T1 (de) Iod-herstellungszusammensetzung
ATE222499T1 (de) Pharmazeutische zusammensetzung enthaltend einen embryonalen extrakt und verfahren zu ihrer herstellung
DK0450123T3 (da) Farmaceutisk præparat til topisk administration indeholdende dichlofenac-natrium
SE9902742D0 (sv) New pharmaceutical formultion
ES2040891T3 (es) Nuevo sistema plastificante hidrofilo y goma de mascar que contiene el mismo.
ES469749A1 (es) Un procedimiento para la preparacion de una formulacion far-maceutica de una droga de notroimidazol.
BR9813037A (pt) Composto, processo para sua preparação, uso do mesmo, preparação farmacêutica, e, combinação desta com pelo menos uma outra substância ativa
CO4370014A1 (es) Soluciones inyectables estables de diritromicina
AU6511074A (en) PHARMACOLOGICALLY ACTIVE 4, 8-DIMETHOXY-FURO-(3',2'-F) BENZOXAZOL-2-yl ACETHYDROXAMIC ACID